{"id":"W4379336249","doi":"10.1200/jco.2023.41.16_suppl.4099","title":"A phase II study of olaparib and durvalumab in patients with IDH-mutated cholangiocarcinoma.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Olaparib; Medicine; Durvalumab; Internal medicine; PARP inhibitor; Oncology; Interim analysis; Intrahepatic Cholangiocarcinoma; Phases of clinical research; Gastroenterology; Surgery; Cancer; Chemotherapy; Clinical trial; Immunotherapy; Poly ADP ribose polymerase; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001791416,0.001460506,0.002140668,0.0004535081,0.0003875271,0.0008981216,0.000849051,0.001103078,0.003751678],"category_scores_gemma":[0.001002979,0.0008823671,0.001212306,0.0004951028,0.0008491033,0.0009353675,0.0004213377,0.002546587,0.0009983786],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001154803,"about_ca_system_score_gemma":0.001930241,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009893846,"about_ca_topic_score_gemma":0.002637899,"domain_scores_codex":[0.9994358,0.0002801538,0.00003371669,0.00008354962,0.00005534266,0.0001112968],"domain_scores_gemma":[0.9991494,0.0001502029,0.0001298091,0.00007738548,0.00005219591,0.0004409817],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7861115,0.09826797,0.007898593,0.0006862273,0.001068668,0.0004080912,0.0003272176,0.002211837,0.02413067,0.0003407092,0.002899057,0.07564945],"study_design_scores_gemma":[0.7145907,0.2738853,0.006085445,0.0000206643,0.0002414046,0.0002453412,0.00005168177,0.00108535,0.001551044,0.0001414038,0.002081339,0.00002032551],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902592,0.001703585,0.0005190898,0.0004910183,0.0001610725,0.003627435,0.001036135,0.00007320788,0.002129381],"genre_scores_gemma":[0.9868454,0.001574726,0.002152564,0.0009546483,0.0002031476,0.003751716,0.002046014,0.00002564545,0.002446149],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003751678,"threshold_uncertainty_score":0.01255059,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.104374228859943,"score_gpt":0.4519795389747411,"score_spread":0.3476053101147981,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}